Global Guillain-Barre Syndrome (GBS) Market

$3,000.00$7,500.00

  • Type: Rare Disease Area
  • Published : March 2021
  • Region: Worldwide
  • Country: Other
  • Report ID : 294

  • Format: PPT, PDF

Global Guillain-Barre Syndrome Market – Size, Share, Trends and Forecasts (2019-2028)

Clear

Report Overview

The global GBS drugs market size is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period.

Guillain-Barre syndrome is a rare condition concerning the immune system of the body. In Guillain-Barre syndrome, the body’s immune system starts attacking the body’s own nervous system, resulting in pain and loss of sensation, as well as weakness and a pins and needles feeling in the limbs. However, the disease has often been seen to be accompanied by respiratory infections and the stomach flu. Growing awareness about Guillain-Barré syndrome is likely to be a major driver for the global Guillain-Barre syndrome market. Effective healthcare measures have resulted in the discovery of effective cures for many of the most common diseases seen around the world. This has in turn increased the visibility of rare diseases, resulting in increasing research and development in the field of discovering cures for rare diseases, including Guillain-Barre syndrome. The increasing investment from pharmaceutical companies in the field of discovering cures for rare diseases is likely to be a stimulant for the global Guillain-Barre syndrome market over the forecast period

Market Drivers

Increasing number of patients with GBS, family history of GBS, strong product pipeline, and increasing financial support to researchers for developing new innovative drugs for treatment of GBS are likely to drive the GBS market during the forecast period. In addition, increase in special designation from the regulatory authorities to offer a treatment to the patients as quickly as possible is enhancing the market. The growing geriatric population is also likely to be a major driver for the global Guillain-Barré syndrome market over the forecast period. Immune system disorders are often seen more commonly in the elderly than in younger demographics. The rising prevalence of chikungunya is also a key driver for the global Guillain-Barre syndrome market, as chikungunya is often accompanied by Guillain-Barre syndrome

GBS Market by Disease

By disease indication, the GBS is segmented into AIDP, MFS, AMAN, and others. The most common type of GBS seen in the United States is acute inflammatory demyelinating polyneuropathy (AIDP). In AIDP, the immune response damages the myelin coating and interferes with the transmission of nerve signals

1. Global GBS Market Overview…………………………………………………
A. Market Size
2. Market Growth Drivers………………………………………………………………….
A. Rise in Global Prevalence of GBS
B. Growing R&D Investments and Reimbursement Policies
3. Major GBS……………………………………………………………………………………..
A. AIDP
B. MFS
C. AMAN
D. Others
4. GBS Market Segmentation………………………………………………….
A. By Therapeutics
I. Intravenous Immunoglobulin
II. Plasma Exchange
III. Others
B. By Distribution Channel
I. Hospital Pharmacies
II. Online Pharmacies
III. Retail Pharmacies
C. By Geography
I. North America Market Analysis
II. Europe Market Analysis
III. Asia-Pacific Market Analysis
IV. Middle-East and Africa Market Analysis
5. GBS Major Drugs Market Share…………………………………………
A. Market Analysis, Insights and Forecast – By Revenue
6. Competitive Landscape…………………………………………………………………
A. Major Players
B. Products in Pipeline
7. Key Company Profiles…………………………………………………………………..
A. Akari Therapeutics Overview, Product & Services, Strategies & Financials
B. CuraVac Inc Overview, Product & Services, Strategies & Financials
C. Annexon Inc Product & Services, Strategies & Financials
8. Healthcare Policies and Regulatory Landscape……………………………………
A. Policy changes and Reimbursement scenario
9. Factors Driving Future Growth…………………………………………………………
A. New Trends and Development of GBS Market
B. Future Opportunities
10. Conclusion

Market Segmentation

By Therapeutics:

Based on therapeutics, the market is segmented into intravenous immunoglobulin, plasma exchange and others. Intravenous immunoglobulins are expected to hold the largest market share in the global Guillain-Barre Syndrome market. The Intravenous immunoglobulins are expected to account for the largest share in the market which can be attributed to availability of wide range of IVIG products such as Gamunex, Gammagard, and Privigen in the market and increased adoption of treatment by off-label use of intravenous immunoglobulins due to rising prevalence of multifocal motor neuropathy, dermatomyositis, polymyositis, stiff person syndrome, and relapsing-remitting multiple sclerosis. Furthermore, the rise in early approvals by regulatory agencies for intravenous immunoglobulin (IVIG) products along with rising government support to increase plasma yield are likely to drive the market during the forecast period.

By Distribution Channel:

In terms of distribution channel, the global GBS treatment market can be divided into hospital pharmacies, retail pharmacies, and online sales. The hospital pharmacies segment generated the highest revenue in 2019 and is anticipated to witness growth during the forecast period due to most of major products are prescription products, which is available in hospital pharmacies

By Region:

By region, North America accounts the largest market share due to the presence of high healthcare expenditure and research and development. Europe accounts the second largest market share due to increased neurological disorders and presence of refined medical facilities. Asia-Pacific is expected to account for the largest market share over coming years for the Guillain-Barre Syndrome market due to increased advancement in the technology as well as growing healthcare expenditure

Top 5 Major Players

The global GBS Market is highly competitive, and the prominent players in the market have adopted various strategies to garner maximum market share. These include collaboration, product launch, partnership, and acquisition. Major players operating in the market include Akari Therapeutic Plc., Annexon Inc., CuraVac Inc., Shire and, Grifols S.A

Research Methodology

Insights10 will provide you reports within 10 key parameters which are:

  1. Market overview
  2. Market growth drivers & restraints
  3. Epidemiology or disease type
  4. Market segmentation
  5. Market share
  6. Competitive landscape
  7. Key company profiles
  8. Healthcare policies & regulatory framework
  9. Reimbursement scenario
  10. Factors driving future growth

Based on our many years of experience, we believe that these are the parameters that are critical to decision making for business stakeholders. Our focused approach to develop reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.

Our analysis methodology involves three critical stages:

Stage I: Market Data Collection

Primary Interviews: We have developed a network of experts, freelancers and researchers across countries through which we engage with local experts to gather key data points and assumptions around each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.

Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain the high level of accuracy and consistency. The market data is analysed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, market share as well as segment-level analysis of the specific market. Our report includes precise, to the point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.

Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:

  • Statistical Databases
  • Company Websites/Annual Reports
  • Trade Publications
  • Online Databases
  • Published Research Reports
  • Whitepapers
  • Press Releases of Key Market Players

Stage II: Market Data Analysis and Statistical Model

Market Trends: We generally look at macro parameter and micro indicators. The macro parameters includes changes in government policies, demand and supply of the market, government intervention programs and major market share. The micro indicators GDP growth, market size, market volume etc. We also understand nuances specific to each country like US, Canada, India, Germany, etc. and have worked across 60+ countries and hence no only understand global trends, but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.

Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. start with large overall market and segment different areas and bottom-up approach i.e. start with population and epidemiology and roll up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.

The top-down approach mainly used for new product forecasting and bottom-up approach is used for demand estimation of any product for different countries summed up to form total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.

The study on the market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and Africa for the period of 2020 to 2028. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape and policy and regulatory scenario and the quantitative analysis covers different market estimates and forecasts.

Data Triangulation & Validation:

Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases and the company level averages etc.

We make sure to finalize the numbers in alignment to the market research. Firstly, our internal experts ensure thorough validation and checking to ensure the accurate and precise analysis and then validation is also done using multiple data analysis model.  Two level validation is done and entails finalization of report scope and to way of representation pattern.

Stage III: Interpretation and Presentation

Analysis & Interpretation: The information gathered is then analysed and synthesized. A second series of interviews are done if necessary to check and validate. The future opportunities are analysed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results are then, interpreted by considering following parameters: (a partial list)

  • Establishing market drivers and trends
  • Analyzing regulatory landscape to understand future growth
  • Market Segment based analysis to obtain revenue / volume
  • Analyzing current needs and determining penetration to estimate market

Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to offer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and its impact to the different segments within the market.
Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.

Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumptions.
The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.

To request a free sample copy this report, please complete the form below.

    We value your inquiry and offer free customization with every report to fulfil your exact research needs.

    This website is secure and your personal details are safe.



    This report addresses

    • Market intelligence to enable effective decision making
    • Growth opportunities and trend analysis
    • Competitive benchmarking
    • Historical data & forecasts
    • Regional opportunities

    Need more?

    • Speak to our analyst to know how this research was put together
    • Add more countries or regions as part of customisation
    • Understand how this report can have direct impact on your revenue

    Get a custom report based on your requirements